Abstract
Background
The prognosis in patients with idiopathic membranous nephropathy (IMN) is diverse. However, the prognosis after relapse and factors affecting relapse remain unclear.
Methods
A total of 146 Japanese patients with IMN who had been followed up for at least 3 years, or until end-stage renal failure or death were enrolled in this retrospective study. The initial clinicopathological factors were examined between the patients with and without relapse. The patients were assigned to two groups based on the electron microscopic findings: homogeneous type with synchronous electron-dense deposits and heterogeneous type with various phases of dense deposits.
Results
A total of 105 of the 146 patients (72 %) achieved complete remission (CR) or incomplete remission (ICR) I after initial treatment. Twenty-six of the 105 patients relapsed after CR or ICR I (25 %). There were no differences in initial clinical findings or data between the patients with and without relapse, except for the higher degree of proteinuria at onset in patients with relapse. The relapse rate of the heterogeneous group (43 %) was higher than that in the homogeneous group (20 %). There were no significant associations between relapse rate and immunosuppressive therapy at onset. Eleven of 26 patients showing relapse (42 %) achieved CR or ICR I, which was lower than the rate for patients with initial remission.
Conclusion
Our results suggest that patients with relapse achieved CR or ICR I and that electron microscopic findings demonstrating heterogeneous type indicated susceptibility to relapse.
Similar content being viewed by others
References
Noel LH, Zanetti M, Droz D, Barbanel C. Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. Am J Med. 1979;66:82–90.
Kida H, Asamoto T, Yokoyama H, Tomosugi N, Hattori N. Long-term prognosis of membranous nephropathy. Clin Nephrol. 1986;25:64–9.
Cameron JS. Membranous nephropathy—still a treatment dilemma. N Engl J Med. 1992;327:638–9.
Marx BE, Marx M. Prognosis of idiopathic membranous nephropathy: a methodologic meta-analysis. Kidney Int. 1997;51:873–9.
Ogi M, Yokoyama H, Tomosugi N, et al. Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome. Am J Kidney Dis. 1994;24:427–36.
Reichert LJM, Koene RAP, Wetzels JF. Prognostic factor in idiopathic membranous nephropathy. Am J Kidney Dis. 2001;31:1–11.
Wu Q, Jinde K, Nishina M, et al. Analysis of prognostic predictors in idiopathic membranous nephropathy. Am J Kidney Dis. 2001;37:380–7.
Wakai S, Magil AB. Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney Int. 1992;41:428–34.
Marx BE, Marx M. Prediction of idiopathic membranous nephropathy. Kidney Int. 1999;56:666–73.
Ehrenreich T, Churg J. Pathology of membranous nephropathy. Pathol Ann. 1968;3:145–86.
Ehrenreich T, Porush JG, Churg J, et al. Treatment of idiopathic membranous nephropathy. N Engl J Med. 1976;295:741–6.
Yokoyama H, Goshima S, Wada T, et al. The short- and long-term outcomes of membranous nephropathy treated with intravenous immune globulin therapy. Nephrol Dial Transplant. 1999;14:2379–86.
Yoshimoto K, Yokoyama H, Wada T, et al. Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy. Kidney Int. 2004;65:148–53.
Rosen S, Tornroth T, Bernard DB. Membranous glomerulonephritis. In: Tisher CC, Brenner BM, editors. Renal pathology with clinical and functional correlations. Philadelphia: JB Lippincott Company; 1989. p. 196–227.
Manos J, Short CD, Acheson EJ, et al. Relapsing idiopathic membranous nephropathy. Clin Nephrol. 1982;18:286–90.
Tornroth T, Honaken E, Pettersson E. The evolution of membranous glomerulonephritis reconsidered: new insight from a study on relapsing disease. Clin Nephrol. 1987;28:107–17.
Ponticelli C, Passerini P, Altieri P, Locatelli F, Pappalettera M. Remissions and relapses in idiopathic membranous nephropathy. Nephrol Dial Transplant. 1992;7:85–90.
Wadi N, Trimarchi H, Pedro J. Relapsing membranous nephropathy. Am J Nephrol. 2001;31:1–11.
Eriguchi M, Oka H, Kamimura T, Sugawara K, Harada A. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and predonisolone. Nephrol Dial Transplant 2009;24:3082–8.
Yuan J, Fang W, Zhang W, Ni Z, Qian J. Treatment of nephrotic idiopathic membranous nephropathy with monthly i.v. pulse cyclophosphamide and oral steroids: a single center’s retrospective study. Nephrology. 2011;16:440–5.
Bohdan J, Cattran C. Prognosis after complete remission in adult patients with idiopathic membranous nephropathy. Am J Kidney Dis. 1999;33:1026–32.
Acknowledgments
This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan.
Conflict of interest
The authors have declared that no Conflict of interest exists.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kitajima, S., Furuichi, K., Sakai, N. et al. Relapse and its remission in Japanese patients with idiopathic membranous nephropathy. Clin Exp Nephrol 19, 278–283 (2015). https://doi.org/10.1007/s10157-014-0987-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-014-0987-9